selection

Nicole Scholz

This tag is associated with 40 posts

A pharmaceutical strategy for Europe: First steps

On 1 June 2020, the European Commission published a roadmap for a pharmaceutical strategy for Europe. The strategy will have the overall goal of ensuring Europe’s supply of safe and affordable medicines and supporting the European pharmaceutical industry’s innovation efforts. Continue reading

European Centre for Disease Prevention and Control: During the pandemic and beyond

The European Centre for Disease Prevention and Control (ECDC) is a decentralised European Union (EU) agency based in Stockholm, Sweden. Continue reading

Organ donation and transplantation: Facts, figures and European Union action [Policy Podcast]

The issue of organ donation and transplantation gained renewed political momentum as one of the initial health priorities of the current Croatian Presidency of the Council of the EU. Continue reading

Addressing shortages of medicines [Policy Podcast]

Medicines shortages have been a growing problem in the European Union (EU) in recent years. As the coronavirus outbreak unfolds, the risk of bottlenecks in the supply of medicines to patients has become particularly high. Continue reading

What can the EU do to alleviate the impact of the coronavirus crisis?

The novel coronavirus (COVID-19) outbreak has now been declared a pandemic by the World Health Organization. Alleviating the human effects of the crisis is paramount, but repercussions are being felt across many sectors. Continue reading

Economic impact of epidemics and pandemics [Policy Podcast]

Despite significant medical progress over the last centuries, infectious diseases such as influenza or malaria still represent a considerable threat to society. While some are endemic to specific geographical regions, others can spread, becoming epidemics or pandemics. Continue reading

Cross-border threats to health: EU action on preparedness and response [Policy podcast]

Serious threats to health – such as those due to infectious disease outbreaks or environmental factors – do not respect borders. They do, however, require cross-border cooperation and a coordinated response. Continue reading

World Aids Day 2019

Every year, 1 December marks World AIDS Day, proclaimed by the United Nations (UN) in 1988 and aimed mainly at raising awareness. This year’s specific theme, ‘Communities make a difference’, draws attention to the crucial role of community health workers and communities of people living with HIV, highlighting their contribution to ending the epidemic. World AIDS Day also offers an opportunity to take stock of progress, globally and in the EU. Continue reading

Health threats from climate change: The time to act is now

On 1 October, the European Parliamentary Research Service (EPRS) hosted the European Academies’ Science Advisory Council (EASAC) for a policy roundtable on climate change and human health. Continue reading

Mobile phones and health: Where do we stand?

Mobile phones are an integral part of everyday life, and it is hard to imagine a world without them. There are nevertheless health concerns, and the debate is ongoing. Continue reading

EU policies – Delivering for citizens: Health and social security [Policy Podcast]

While the main responsibility for health and social security lies primarily with the governments of the individual European Union (EU) Member States, the EU complements national policies, especially those having a cross-border dimension. Continue reading

Limits on exposure to carcinogens and mutagens at work: Third proposal [EU Legislation in Progress]

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. Continue reading

Boosting cooperation on health technology assessment [EU Legislation in Progress]

The European Commission has proposed a regulation on health technology assessment (HTA). HTA is a research-based tool that supports decision-making in healthcare by assessing the added value of a given health technology compared to others. Continue reading

Parliament rejects criteria for endocrine disruptors

Endocrine disruptors, or endocrine-disrupting chemicals (EDCs), are substances that impact on the functioning of hormones, with potentially harmful effects on health. Continue reading

Smoke-free for better health [What is Europe doing for its citizens?]

Written by Nicole Scholz, Smoking is the largest preventable cause of death in Europe. In the past decade, EU laws on tobacco additives, advertising and packaging have reinforced efforts to deter people, especially the young, from taking up smoking. The ‘Ex-Smokers are Unstoppable’ campaign has helped many kick the habit. Today, taking their lead from … Continue reading

Limits on exposure to carcinogens and mutagens at work: Second proposal [EU Legislation in Progress]

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. Continue reading

Medical devices and in vitro diagnostic medical devices [EU Legislation in Progress]

Written by Nicole Scholz (4th edition) Medical devices and in vitro diagnostic medical devices cover a wide array of products. The EU legal framework for such devices was harmonised in the 1990s. The European Commission presented a pair of proposals for regulations in September 2012. Following Parliament’s first readings in April 2014, the Council agreed … Continue reading

World Health Day 2017 – ‘Depression: Let’s talk’

Written by Nicole Scholz, 7 April each year is ‘World Health Day’, marking the anniversary of the World Health Organization (WHO), founded in 1948. World Health Day is one of the WHO’s eight official health days for raising awareness and mobilising people to act. This year’s focus is on depression. The WHO campaign has three … Continue reading

Medical devices and in vitro diagnostic medical devices [Plenary Podcast]

Written by Nicole Scholz, The current EU approval system for medical devices (MDs) and in vitro diagnostic medical devices (IVDs) is based on conformity assessment by ‘notified bodies’. A number of scandals stressed the need to tighten the regulatory framework for such devices. The European Commission’s proposals for regulations on MDs and IVDs, being discussed … Continue reading

4 February: World Cancer Day

Written by Nicole Scholz, World Cancer Day is a global awareness-raising initiative of the Union for International Cancer Control (UICC), supported by the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC). The initiative aims to spread the word about cancer and prod governments and individuals into action, with a view … Continue reading

Download the EPRS App

EPRS App on Google Play
EPRS App on App Store
What Europe Does For You
EU Legislation in Progress
Topical Digests
EPRS Podcasts

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 3,343 other followers

Disclaimer and Copyright statement

The content of all documents (and articles) contained in this blog is the sole responsibility of the author and any opinions expressed therein do not necessarily represent the official position of the European Parliament. It is addressed to the Members and staff of the EP for their parliamentary work. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.

For a comprehensive description of our cookie and data protection policies, please visit Terms and Conditions page.

Copyright © European Union, 2014-2019. All rights reserved.